Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Heliox om arbeidet med å puste hos voksne pasienter med stenose i nedre luftveier

18. september 2026 oppdatert av: Marta Corral Blanco, Hospital Universitario 12 de Octubre

Effekten av Heliox på arbeidet med å puste hos voksne pasienter med stenose i nedre luftveier

Heliox (a mixture of Helium and Oxygen) can reduce the work of breathing in patients with airway stenosis by modifying turbulent flow into laminar flow. The aim of this study was to analyze the effect of Heliox versus conventional oxygen therapy in patients with lower airway stenosis on muscular effort measured by electromyography and diaphragmatic ultrasound, thoracoabdominal synchrony assessed with plethysmographic bands, dyspnea, stridor, oxygen saturation, transcutaneous carbon dioxide value, blood pressure, heart rate and respiratory rate.

Studieoversikt

Status

Fullført

Forhold

Intervensjon / Behandling

Detaljert beskrivelse

Lower airway stenosis results in increased work of breathing with stridor and dyspnea, as a consequence of the increased resistances caused by the reduction in airway diameter. Airway resistance also depends on the length of the airway and the type of gas flow. Heliox (a mixture of Helium and Oxygen) is a gas less dense than air, which can change the flow from turbulent to laminar, reducing airway resistance by 20 to 40%, and therefore decreasing the work of breathing. Heliox is an inert gas that does not react with biological membranes, so there are few complications associated with its use, the most relevant being hypoxemia when fixed mixtures are not used and the the fraction of inspired oxygen (FiO2) supplied is less than 21%. The aim of the study was to evaluate if during the perioperative period of lower airway stenosis the administration of Heliox compared to oxygen could reduce the work of breathing and improve dyspnea. For this purpose, patients were treated for 30 minutes with Heliox (fixed mixture of 70% helium and 30% oxygen) using a non rebreather mask or reservoir bag versus 30 minutes with oxygen 31% using a Venturi mask.

Studietype

Observasjonsmessig

Registrering (Faktiske)

18

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Madrid
      • Madrid, Madrid, Spania, 28041
        • Marta Corral Blanco

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 80 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Patients will be recluted from the pneumology outpatient clinic of the Hospital 12 de Octubre

Beskrivelse

Inclusion Criteria:

  • Patients with lower airway stenosis evaluated at the Respiratory Endoscopy Unit of the Hospital Universitario 12 de Octubre on the waiting list for endoscopic intervention on stenosis.
  • Stenosis grade ≥ 3 and Borg scale score > 2.

Exclusion Criteria:

  • Presence of relevant comorbidities (uncontrolled ischemic heart disease, ventricular dysfunction, pneumopathies with severe respiratory insufficiency, severe pulmonary hypertension).
  • Inability to perform the test due to severe dyspnea or need for emergency intervention.
  • Patient on continuous mechanical ventilation, invasive or non-invasive.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Airway Stenosis

Patients with lower airway stenosis on waiting list for endoscopic intervention on stenosis by respiratory endoscopy unit.

Treatment for 30 minutes with Heliox from a commercial tank (Oxhelⓒ, Air Liquideⓒ) with a fixed mixture of 70% helium and 30% oxygen with non-rebreather mask or reservoir bag at a flow of 12-15 lpm.

Andre navn:
  • Helium - Oksygen

Treatment for 30 minutes with oxygen at FiO2 of 31% with Venturi mask.

Andre navn:
  • Oksygen 31 %

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Changes in Neural Ventilatory Drive (%):
Tidsramme: 30 minutes with Heliox and 30 minutes with Oxygen 31%

Percentage over the Root Mean Square peak for parasternal electromyography (EMG): averaged of the square root of the peak value and the area under the curve of parasternal EMG (%RootMeanSquare) adjusted for respiratory frequency, as a surrogate of diaphragmatic EMG, and sternocleidomastoid EMG, which will give us information on accessory muscle activation.

30 minutes with Heliox and 30 minutes with Oxygen 31%

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Diaphragmatic excursion assessed with ultrasound
Tidsramme: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.

Assessment of muscular effort by measuring the diaphragmatic excursion (mm) at tidal volume and at vital capacity.

At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Thickening fraction of the diaphragm assessed by ultrasound
Tidsramme: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.

Assessment of muscular effort by measuring the thickening fraction of the diaphragm in the apposition zone (%).

At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
Changes in thoracoabdominal synchrony
Tidsramme: Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Assessment of thoracoabdominal synchrony using thoracic and abdominal belts by calculating the phase angle with the Lissajoux loop method (plotting abdominal motion on the x-axis against thoracic motion on the y-axis).

Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Borg Scale Dyspnea evolution (points)
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Oxygen saturation
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Measured by pulse-oximetry

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Transcutaneous partial pressure of carbon dioxide
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2)

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Blood pressure
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Non-invasive measurement with a sphygmomanometer

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Heart rate
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

number of beats per minute

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
Respiratory rate
Tidsramme: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Number of breaths per minute

Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Marta Corral Blanco, MD, Hospital 12 de Octubre

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

27. april 2022

Primær fullføring (Faktiske)

31. mai 2023

Studiet fullført (Faktiske)

10. januar 2026

Datoer for studieregistrering

Først innsendt

30. mai 2024

Først innsendt som oppfylte QC-kriteriene

7. juni 2024

Først lagt ut (Faktiske)

13. juni 2024

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

23. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • HELIOX ON AIRWAY STENOSIS

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .